This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Institut Pasteur, Other. Active years: 2017-2022.
Company Filing History:
2 out of 898 
2 out of 834,453 Years Active: 2017-2022
Title: The Innovations of Mathieu Picardeau
Introduction
Mathieu Picardeau is a notable inventor based in Paris, France. He has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 4 patents, his work focuses on eliciting immune responses in animals against various infections.
Latest Patents
One of his latest patents is a live attenuated heterologous vaccine. This invention provides compositions or vaccines that contain a recombinant or an attenuated agent that elicits an immune response in animals against specific infections. Additionally, he has developed immunoprotective proteins and methods for their identification and use. This invention offers compositions and methods for eliciting heterologous protective immunity in animals against certain pathogens, with immunoprotective peptides that elicit protective immunity against subsequent challenges.
Career Highlights
Throughout his career, Mathieu Picardeau has worked with prestigious institutions, including the Institut Pasteur. His research has significantly advanced the understanding of vaccine development and immunology.
Collaborations
Mathieu has collaborated with esteemed colleagues such as Sylvie Dartevelle and Pascale Bourhy. Their joint efforts have contributed to the success of various research projects and innovations in the field.
Conclusion
Mathieu Picardeau's work exemplifies the impact of innovative research in vaccine development. His contributions continue to influence the field of immunology and enhance our understanding of protective immunity.